Nalaganje...
How We Treat Febrile Neutropenia in Patients Receiving Cancer Chemotherapy
Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Clinical Oncology
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2868641/ https://ncbi.nlm.nih.gov/pubmed/20808559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.091092 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|